Form 8-K - Current report:
SEC Accession No. 0001062993-18-000349
Filing Date
2018-01-30
Accepted
2018-01-29 19:26:17
Documents
4
Period of Report
2018-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 7370
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 43319
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8482
4 GRAPHIC graphic.jpg GRAPHIC 1538
  Complete submission text file 0001062993-18-000349.txt   62723
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 18557198
SIC: 1000 Metal Mining